SUBSCRIBE
SUBSCRIBE

Zai Lab (US) LLC

NEWS
Business
Biopharma Companies Entering 2021 With New Collabs, Partnerships
Here’s a run-down of some of the most recent collaboration announcements this week.
January 8, 2021
 · 
4 min read
 · 
Brandon May
Business
BioSpace Movers & Shakers. Dec. 4
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
December 3, 2020
 · 
7 min read
 · 
Alex Keown
Load More
JOBS
IN THE PRESS
Press Releases
Zai Lab Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia
January 17, 2025
 · 
7 min read
Press Releases
Zai Lab Announces Positive Topline Results for TIVDAK in the China Subpopulation of the Global Phase 3 innovaTV 301 Trial in Patients with Recurrent or Metastatic Cervical Cancer
January 15, 2025
 · 
9 min read
Press Releases
Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore
January 10, 2025
 · 
9 min read
Press Releases
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore
January 10, 2025
 · 
9 min read
Press Releases
Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate
January 10, 2025
 · 
5 min read
Press Releases
Zai Lab Announces Participation in Investor Conference in January 2025
December 12, 2024
 · 
1 min read
Press Releases
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer
December 2, 2024
 · 
8 min read
Press Releases
Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List
November 28, 2024
 · 
8 min read
Press Releases
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)
November 21, 2024
 · 
10 min read
Press Releases
Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares
November 18, 2024
 · 
5 min read
Load More